Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares have popped more than 6% in the pre-market after the company released additional 48-week data from the AURA-LV study at the National Kidney Foundation 2017 Spring Clinical Meetings. The data showed continued improvements in renal and extra-renal…
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
April 21, 2017 at 06:04PM
from Insider Monkey Team
No comments:
Post a Comment